Literature DB >> 27611085

Novel protective mechanism of reducing renal cell damage in diabetes: Activation AMPK by AICAR increased NRF2/OGG1 proteins and reduced oxidative DNA damage.

Samy L Habib1,2, Anamika Yadav1, Dawit Kidane3, Robert H Weiss4, Sitai Liang1.   

Abstract

Exposure of renal cells to high glucose (HG) during diabetes has been recently proposed to be involved in renal injury. In the present study, we investigated a potential mechanism by which AICAR treatment regulates the DNA repair enzyme, 8-oxoG-DNA glycosylase (OGG1) in renal proximal tubular mouse cells exposed to HG and in kidney of db/db mice. Cells treated with HG for 2 days show inhibition in OGG1 promoter activity as well as OGG1 and Nrf2 protein expression. In addition, activation of AMPK by AICAR resulted in an increase raptor phosphorylation at Ser792 and leads to increase the promoter activity of OGG1 through upregulation of Nrf2. Downregulation of AMPK by DN-AMPK and raptor and Nrf2 by siRNA resulted in significant decease in promoter activity and protein expression of OGG1. On the other hand, downregulation of Akt by DN-Akt and rictor by siRNA resulted in significant increase in promoter activity and protein expression of Nrf2 and OGG1. Moreover, gel shift analysis shows reduction of Nrf2 binding to OGG1 promoter in cells treated with HG while cells treated with AICAR reversed the effect of HG. Furthermore, db/db mice treated with AICAR show significant increased in AMPK and raptor phosphroylation as well as OGG1 and Nrf2 protein expression that associated with significant decrease in oxidative DNA damage (8-oxodG) compared to non-treated mice. In summary, our data provide a novel protective mechanism by which AICAR prevents renal cell damage in diabetes and the consequence complications of hyperglycemia with a specific focus on nephropathy.

Entities:  

Keywords:  AICAR; AMPK; Nrf2; OGG1; diabetes; mTOR

Mesh:

Substances:

Year:  2016        PMID: 27611085      PMCID: PMC5134712          DOI: 10.1080/15384101.2016.1231259

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  34 in total

1.  Can patients with type 2 diabetes be treated with 5'-AMP-activated protein kinase activators?

Authors:  W W Winder
Journal:  Diabetologia       Date:  2008-08-12       Impact factor: 10.122

2.  Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients.

Authors:  H Sakuraba; H Mizukami; N Yagihashi; R Wada; C Hanyu; S Yagihashi
Journal:  Diabetologia       Date:  2002-01       Impact factor: 10.122

3.  An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements.

Authors:  K Itoh; T Chiba; S Takahashi; T Ishii; K Igarashi; Y Katoh; T Oyake; N Hayashi; K Satoh; I Hatayama; M Yamamoto; Y Nabeshima
Journal:  Biochem Biophys Res Commun       Date:  1997-07-18       Impact factor: 3.575

4.  AMP-activated protein kinase protects cardiomyocytes against hypoxic injury through attenuation of endoplasmic reticulum stress.

Authors:  Kazuo Terai; Yoshimune Hiramoto; Mitsuru Masaki; Shoko Sugiyama; Tadashi Kuroda; Masatsugu Hori; Ichiro Kawase; Hisao Hirota
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

5.  Activity of OGG1 variants in the repair of pro-oxidant-induced 8-oxo-2'-deoxyguanosine.

Authors:  D J Smart; J K Chipman; N J Hodges
Journal:  DNA Repair (Amst)       Date:  2006-07-24

6.  The mitochondrial K-ATP channel opener, diazoxide, prevents ischemia-reperfusion injury in the rabbit spinal cord.

Authors:  Glen Roseborough; Daqing Gao; Lei Chen; Michael A Trush; Shaoyu Zhou; G Melville Williams; Chiming Wei
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

7.  Tuberin regulates the DNA repair enzyme OGG1.

Authors:  Samy L Habib; Daniel J Riley; Lenin Mahimainathan; Basant Bhandari; Goutam Ghosh Choudhury; Hanna E Abboud
Journal:  Am J Physiol Renal Physiol       Date:  2007-11-07

Review 8.  Glucose and reactive oxygen species.

Authors:  Dominique Bonnefont-Rousselot
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2002-09       Impact factor: 4.294

9.  Tuberin inhibits production of the matrix protein fibronectin in diabetes.

Authors:  Samy L Habib; Mukesh Yadav; Shaza Tizani; Basant Bhandari; Anthony J Valente
Journal:  J Am Soc Nephrol       Date:  2012-08-16       Impact factor: 10.121

10.  Urinary excretion of 8-oxo-7, 8-dihydro-2'-deoxyguanosine as a predictor of the development of diabetic nephropathy.

Authors:  Y Hinokio; S Suzuki; M Hirai; C Suzuki; M Suzuki; T Toyota
Journal:  Diabetologia       Date:  2002-05-08       Impact factor: 10.122

View more
  16 in total

1.  Histone demethylase UTX is a therapeutic target for diabetic kidney disease.

Authors:  Hong Chen; Yixue Huang; Xiuqin Zhu; Chong Liu; Yangmian Yuan; Hua Su; Chun Zhang; Chengyu Liu; Mingrui Xiong; Yannan Qu; Peng Yun; Ling Zheng; Kun Huang
Journal:  J Physiol       Date:  2018-12-25       Impact factor: 5.182

2.  cAMP-independent non-pigmentary actions of variant melanocortin 1 receptor: AKT-mediated activation of protective responses to oxidative DNA damage.

Authors:  María Castejón-Griñán; Cecilia Herraiz; Conchi Olivares; Celia Jiménez-Cervantes; Jose Carlos García-Borrón
Journal:  Oncogene       Date:  2018-04-06       Impact factor: 9.867

Review 3.  Energy sensing pathways: Bridging type 2 diabetes and colorectal cancer?

Authors:  Juhong Yang; Reiko Nishihara; Xuehong Zhang; Shuji Ogino; Zhi Rong Qian
Journal:  J Diabetes Complications       Date:  2017-04-13       Impact factor: 2.852

4.  High-glucose toxicity is mediated by AICAR-transformylase/IMP cyclohydrolase and mitigated by AMP-activated protein kinase in Caenorhabditis elegans.

Authors:  Christin Riedinger; Michael Mendler; Andrea Schlotterer; Thomas Fleming; Jürgen Okun; Hans-Peter Hammes; Stephan Herzig; Peter P Nawroth
Journal:  J Biol Chem       Date:  2018-02-02       Impact factor: 5.157

5.  The Dephosphorylation of p70S6 (Thr389) Kinase as a Marker of L-Glutamate-Induced Excitotoxicity Related to Diabetes Disturbances-an Unconventional In Vitro Model.

Authors:  Anna Rorbach-Dolata; Anna Kicinska; Agnieszka Piwowar
Journal:  Neurotox Res       Date:  2020-01-04       Impact factor: 3.911

Review 6.  Activation of Nrf2 signaling by natural products-can it alleviate diabetes?

Authors:  Manuel Matzinger; Katrin Fischhuber; Elke H Heiss
Journal:  Biotechnol Adv       Date:  2017-12-28       Impact factor: 14.227

7.  Role of Estrogen and Other Sex Hormones in Brain Aging. Neuroprotection and DNA Repair.

Authors:  Sandra Zárate; Tinna Stevnsner; Ricardo Gredilla
Journal:  Front Aging Neurosci       Date:  2017-12-22       Impact factor: 5.750

8.  AMPK leads to phosphorylation of the transcription factor Nrf2, tuning transactivation of selected target genes.

Authors:  Manuel Matzinger; Katrin Fischhuber; Daniel Pölöske; Karl Mechtler; Elke H Heiss
Journal:  Redox Biol       Date:  2019-11-27       Impact factor: 11.799

9.  Protective effects of glucagon-like peptide-1 on cardiac remodeling by inhibiting oxidative stress through mammalian target of rapamycin complex 1/p70 ribosomal protein S6 kinase pathway in diabetes mellitus.

Authors:  Dongjuan Wang; Longfu Jiang; Beili Feng; Nana He; Yue Zhang; Honghua Ye
Journal:  J Diabetes Investig       Date:  2019-07-02       Impact factor: 4.232

Review 10.  Shaping Up Mitochondria in Diabetic Nephropathy.

Authors:  Koki Mise; Daniel L Galvan; Farhad R Danesh
Journal:  Kidney360       Date:  2020-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.